Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- Check7 days agoChange DetectedThe page now communicates that no participants are being enrolled for this rollover study and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting changes and the revision version are updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check14 days agoChange DetectedA new page revision is introduced, showing revision v3.5.5 and replacing v3.5.4. This indicates a page-level update and does not change the study details or their presentation.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 removed. This indicates a minor update to the page's metadata rather than substantive changes to study content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page shows Revision: v3.5.3, indicating a software/template version update. This update is a backend version bump and does not modify the displayed study details.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page revision label changed from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check71 days agoChange DetectedPadua, Italy has been changed to Padova, Italy in the Locations section.SummaryDifference0.0%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.